| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
6,521 |
4,797 |
$5.64M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
1,082 |
832 |
$1.02M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
19,915 |
14,674 |
$797K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,320 |
11,849 |
$552K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,193 |
8,939 |
$506K |
| 92134 |
|
27,982 |
22,831 |
$428K |
| J9035 |
Injection, bevacizumab, 10 mg |
3,747 |
3,176 |
$231K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,565 |
2,357 |
$181K |
| 92015 |
Determination of refractive state |
9,117 |
7,752 |
$96K |
| J7999 |
Compounded drug, not otherwise classified |
3,682 |
2,584 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
355 |
313 |
$32K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
124 |
91 |
$30K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
392 |
325 |
$27K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
785 |
505 |
$25K |
| 92136 |
|
971 |
270 |
$11K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,579 |
1,163 |
$10K |
| 92250 |
|
333 |
280 |
$7K |
| 92235 |
|
163 |
132 |
$6K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
47 |
27 |
$2K |
| 92083 |
|
48 |
41 |
$820.91 |
| 92133 |
|
42 |
39 |
$707.06 |
| 92020 |
|
26 |
25 |
$259.52 |